Article
Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis.
Biochemical genetics - 1 Oct 2022
Tabaei Samira, Omraninava Melodi, Mehranfar Sahar, Motallebnezhad Morteza, Tabaee Seyedeh Samaneh
Abstract excerpt
A systematic review and meta-analysis were conducted to find out if there was association between Plasminogen Activator Inhibitor-1 (PAI-1) gene polymorphisms (- 844 G > A and - 675 4G > 5G) and susceptibility to coronary artery disease (CAD). Search of electronic databases was performed and the pooled odds ratio (OR) and 95% confidence interval (CI) were exerted to evaluate the pooled association between the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
